Notice about cookies

Close

This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy. By clicking Accept below or continuing to use this website (including closing this message), you confirm that you have read and consent to our use of cookies as detailed in our Cookie Policy.

Accept

Go To Global Site
Welcome to UCB in the United States

U.S. Innovation and Partnerships

At UCB, everything we do starts with a simple question: “How will this create value for people living with severe diseases?” To do this, our approach to innovation keeps patients at the center. We use patient insights to inform our science to build solutions to deliver to patients. Innovation is ongoing as we continue to find solutions to meet the unmet needs of patients. We are committed to continuing to innovate – from patient to science to solution. We are inspired by patients and driven by science to deliver what patients value.

Infographic displaying icons for patient, solution, science

 


Digital Business Transformation

Together, we can amplify the power of scientific innovation through digital transformation to create sustainable value, ensuring that patients can live the lives they choose, now and in the future.

For More

TransCelerate Biopharma Inc.

To support a model of open innovation, UCB is engaged in partnerships and efforts to foster value for patients. For example, to foster and accelerate clinical trials, UCB partners with TransCelerate Biopharma Inc. to engage with industry organizations, patients, and global regulatory authorities on best approaches for adapting research models to include patient-driven solutions and data.

Woman pointing at sky with young child on lap

Women of Childbearing Age

A key underserved patient population is women of childbearing age managing chronic conditions. UCB is committed to collaborating with these patients and incorporating their needs in the innovative process. UCB is the industry representative to the National Institutes of Health’s Task Force on Research Specific to Pregnant and Lactating Women.

We are also collaborating with the American Gastroenterological Association to address the lack of easily accessible and accurate information about inflammatory bowel disease for patients of childbearing age.

U.S. CLINICAL TRIALS
PIPELINE
LATEST NEWS

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)